J Gen Virol Try Microbiology Online
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Gen Virol 90 (2009), 634-639; DOI 10.1099/vir.0.008391-0

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Randhawa, P.
Right arrow Articles by Christensen, N. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Randhawa, P.
Right arrow Articles by Christensen, N. D.
Agricola
Right arrow Articles by Randhawa, P.
Right arrow Articles by Christensen, N. D.

Short Communication

Identification of species-specific and cross-reactive epitopes in human polyomavirus capsids using monoclonal antibodies

Parmjeet Randhawa1, Raphael Viscidi2, Joseph J. Carter4, Denise A. Galloway4, Tim D. Culp3, Cathy Huang1, Bala Ramaswami1 and Neil D. Christensen3

1 Department of Pathology, University of Pittsburgh, Pittsburgh, PA 15213, USA
2 Department of Pediatrics, Johns Hopkins University, Baltimore, MD, USA
3 Department of Pathology, Jake Gittlen Cancer Research Foundation, Pennsylvania State University, Hershey, USA
4 Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA, USA

Correspondence
Parmjeet Randhawa
randhawapa{at}upmc.edu

The human antibody response to polyomavirus capsid proteins is not well characterized. Recombinant BK virus (BKV), JC virus (JCV) and simian virus 40 (SV40) virus-like particles (VLP) were produced in a baculovirus system, and mouse monoclonal antibodies (mAbs) to these proteins were generated using standard methods. Nine of 12 BKV mAbs showed neutralizing activity. The non-neutralizing antibodies also bound BKV pseudocapsids in an ELISA binding assay. Most antibodies recognized conformational species-specific epitopes, but several exceptions were found: (i) BKV mAb BK-F11 cross-reacted with a linear buried epitope common to both JCV and SV40 pseudocapsids, (ii) two of six JCV antibodies (JC-6.7 and JC-7.9) and two of 13 SV40 antibodies (VP1-H2 and VP1-I2) recognized linear buried epitopes common to all three viruses and (iii) SV40 antibody VP1-E5 recognized a linear surface epitope on JCV pseudocapsids.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 2009 by the Society for General Microbiology.